165
2022
Study Title
Infusion Related Reactions in Cellular Therapy (INR-RCT)
Study Description
Cellular Therapy is fast expanding and Infusion of Cellular Therapy products is becoming a common procedure in different settings (inpatients, outpatients). In this Review, we will provide a synopsis of the pathophysiology, management and prevention of Cellular Therapy infusion related reactions using evidence-based recommendations whenever available. The information will be presented in a concise, yet comprehensive, user-friendly format. The span will cover ‘traditional’ CT products such as HPC, Cord blood as well as newer therapies such as CAR-T cells.
Study Status
Active
Publication Number
Teams
CT
Study Leaders
Schwartz